跳至主要内容
临床试验/ITMCTR2200005799
ITMCTR2200005799尚未招募1 期

Effect of JieJiXuanFeiChuYi Granule on Patients with COVID 19 (Omicron): A Randomized, Open-label, Active drug Parallel Controlled Trial

The Affiliated Hospital of Changchun University of Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 —(—)
性别
All

入选标准

  • 1. Meet the diagnostic criteria for patients with Covid 19 in the Covid 19 Pneumonia Diagnosis and Treatment Program (Trial Version 9);
  • 2. The clinical classification is mild and moderate;
  • 3. Diagnosed within 72 hours;
  • 4. Have one or more symptoms of fever, cough, and fatigue;
  • 5. The patient's aged >=18 years;
  • 6. Sign the informed consent.

排除标准

  • 1. Severe and Critical type;
  • 2. Women preparing for pregnancy, pregnant and lactating women;
  • 3. Allergic constitution patients (referring to those allergic to two or more drugs or foods or to the known ingredients of the drug in this trial);
  • 4. Mental patients, or patients without self-awareness.
  • 5. Not suitable to participate in clinical trials judged by the investigator.

研究者

发起方
The Affiliated Hospital of Changchun University of Chinese Medicine

相似试验

Effect of JieJiXuanFeiChuYi Granule on Patients with... | 临床试验